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CDC’s Response to Zika 
Counseling Travelers
Women and Men of Reproductive Age Who are Considering Travel 
to Areas with Active Transmission of Zika Virus (ZIKV)
This guide describes recommendations to providers for counseling women and men of reproductive age who are considering travel to areas with active ZIKV transmission. 
This material includes recommendations from CDC’s interim guidance1 and talking points to cover while discussing recommendations.
Recommendation Key Issues Talking Points
Assess risk of Environment Discuss whether Zika is being spread by mosquitoes in the planned area of travel (see CDC Zika Travel Information website*).
Discuss environment in which patient will be staying:  advise traveler to stay in hotel rooms or other accommodations that are air conditioned or ZIKV exposure and 
prevention have good window and door screens to keep mosquitoes outside.
Discuss mosquito bite prevention, including insect repellent, clothing (including permethrin-treated2), and bed net use.
Discuss ZIKV 1. Signs and Many people infected with ZIKV won’t have symptoms or will have only mild symptoms. The most common symptoms of ZIKV disease are fever, 
infection symptoms of rash, arthralgias, and conjunctivitis; other common symptoms include myalgia and headache.
Illness usually lasts about a week. 
ZIKV infection during or just before pregnancy may cause poor pregnancy and infant outcomes, including birth defects.
Guillain-Barré syndrome is possibly triggered by ZIKV in a small proportion of infections, as it is after a variety of other infections.
People who have possibly been exposed and develop symptoms consistent with ZIKV disease should see a healthcare provider and report their 
recent travel.
If travelers develop symptoms of ZIKV disease, they should rest, stay hydrated, and take acetaminophen for fever or pain. To reduce the risk of 
hemorrhage, aspirin or other NSAIDs should not be taken until dengue can be ruled out. 
When travelers return from an area with ZIKV, they should take steps to prevent mosquito bites for 3 weeks if they have no symptoms of ZIKV 











Discuss ZIKV Possible adverse ZIKV can be passed to the fetus during pregnancy or at delivery if a woman is infected around the time of conception or during pregnancy.
infection and outcomes of ZIKV ZIKV infection during pregnancy can cause microcephaly and other severe fetal brain defects.
pregnancy infection during 
pregnancy
Children with microcephaly often have serious problems with development and can have other neurologic problems, such as seizures.
ZIKV has been linked to other problems in pregnancies and among fetuses and infants infected with ZIKV before birth, such as miscarriage, 
stillbirth, defects of the eye, hearing deficits, and impaired growth.
There is no evidence that ZIKV infection poses an increased risk for birth defects in future pregnancies after the virus has cleared from the 
blood.
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Recommendation Key Issues Talking Points
Assess pregnancy 
plans related to 
timing of travel
1. Timing of 
conception 
2. Avoiding travel to 
areas of active 
ZIKV transmission 
while pregnant
CDC recommends that women who are pregnant not travel to any area with active ZIKV transmission.
If a pregnant woman must travel to one of these areas, discuss potential risks and the steps she should take to prevent mosquito bites 
during the trip.
If a traveler is planning to try to conceive either while traveling or after returning, there are important recommendations s/he needs to 
be aware of, including waiting to conceive. There are different recommendations for women and for men based on whether or not they 
develop symptoms consistent with ZIKV disease during or after travel (see table below).
Discuss ZIKV 
infection –  risk of 
sexual transmission 
and need for 
contraception
1. Preventing sexual 
transmission
2. Contraceptioin 
ZIKV can also be transmitted through sex with a male partner.
Men might be bitten by a mosquito and become infected with ZIKV and then infect their sex partners. 
Patients should be advised to take the following steps to protect themselves from sexual transmission of ZIKV:
1. If a man develops symptoms of ZIKV disease, he should use a condom the right way, every time he has vaginal, anal, or oral (mouth-
to-penis) sex or should not have sex for 6 months after illness starts.
2. If a man does not develop symptoms of ZIKV disease, he should still use condoms for at least 8 weeks after the last date of 
exposure (the last day he is in an area with active ZIKV transmission) to avoid sexual transmission to his partner. This is especially 
important if he has any plans to try to conceive with his partner after returning from travel.
To avoid conceiving for the advised periods of time (see table below), a woman or couple should also use the most effective contraceptive 
methods that can be used correctly and consistently (See Effectiveness of Family Planning Methods:  
http://www.cdc.gov/reproductivehealth/unintendedpregnancy/pdf/contraceptive_methods_508.pdf).
Length of time to wait to conceive after travel to areas with active Zika virus transmission
One or more symptoms of ZIKV disease 
(fever, rash, arthralgia or conjunctivitis) Female traveler Male traveler
Yes Wait at least 8 weeks after symptom 
onset to try to conceive
Wait at least 6 months after symptom onset to 
try to conceive with partner
No Wait at least 8 weeks after last date of 
exposure to try to conceive
Wait at least 8 weeks after last date of 
exposure to try to conceive with partner
Related websites:
Zika Virus - http://www.cdc.gov/zika/index.html
* Zika Travel Information - http://wwwnc.cdc.gov/travel/page/zika-travel-information
Guillain-Barré Syndrome - http://www.cdc.gov/zika/about/gbs-qa.html
Zika Virus Prevention - http://www.cdc.gov/zika/prevention/index.html
For Providers Caring for Women with Possible ZIKV Exposure -  
http://www.cdc.gov/zika/hc-providers/qa-pregnant-women.html 
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2. In some places, such as Puerto Rico, there is widespread permethrin resistance, and it is unlikely to be effective. Contact local authorities or a mosquito control district for more information on pesticides.
Zika Transmission & Risks - http://www.cdc.gov/zika/transmission/index.html
Zika Symptoms, Diagnosis & Treatment - http://www.cdc.gov/zika/symptoms/index.html
** For updates, please check http://www.cdc.gov/zika/hc-providers/index.html;  
 updated clinical guidance is marked as “UPDATE” **
